These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25518215)

  • 1. [Support in heart failure: major paradigm shift or small step?].
    Tafer N; Fumeaux T
    Rev Med Suisse; 2014 Oct; 10(447):2004. PubMed ID: 25518215
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart failure: another new PARADIGM in treatment for heart failure?
    Geach T
    Nat Rev Cardiol; 2015 Jan; 12(1):4. PubMed ID: 25445135
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin receptor neprilysin inhibitors in older patients with heart failure.
    Sharkey AT; Ghafar MZ; O'Keeffe ST; Mulkerrin EC
    BMJ Evid Based Med; 2019 Feb; 24(1):5-7. PubMed ID: 29991523
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin receptor-neprilysin inhibitors in heart failure: a shifting paradigm.
    Vardeny O
    Evid Based Med; 2015 Apr; 20(2):61. PubMed ID: 25659916
    [No Abstract]   [Full Text] [Related]  

  • 5. [Risk reduction of acute heart failure with initial administration of beta-blockers].
    Med Monatsschr Pharm; 2007 Apr; 30(4):158. PubMed ID: 17484449
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of candesartan, enalapril and their combination in congestive heart failure].
    Rapezzi C
    Ital Heart J Suppl; 2000 Mar; 1(3):429-30. PubMed ID: 10815278
    [No Abstract]   [Full Text] [Related]  

  • 7. [ACE inhibitors or AT1 receptor antagonists?].
    Riegger GA
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S37-9. PubMed ID: 10535045
    [No Abstract]   [Full Text] [Related]  

  • 8. Renin-angiotensin-aldosterone system inhibitors in heart failure.
    Shearer F; Lang CC; Struthers AD
    Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart Failure Therapy in 2016: SHIFTing the PARADIGM From Antiquated Therapies Toward Novel Agents.
    Jennings DL
    Ann Pharmacother; 2017 Jan; 51(1):79-82. PubMed ID: 27701079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined neutral endopeptidase inhibitors.
    Cuculi F; Erne P
    Expert Opin Investig Drugs; 2011 Apr; 20(4):457-63. PubMed ID: 21323474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Margaret McCartney: Only data can say if new is better.
    McCartney M
    BMJ; 2017 May; 357():j2191. PubMed ID: 28483792
    [No Abstract]   [Full Text] [Related]  

  • 12. [The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial].
    Shimamoto K; Kawana M
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():531-6. PubMed ID: 17511104
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic developments in the therapy of heart failure: lessons to be learned.
    Parker JD
    Eur Heart J; 2015 Aug; 36(30):1952-4. PubMed ID: 26088390
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of combined neprilysin and RAS inhibition in heart failure: A meta-analysis of randomized controlled trials.
    Geng Q; Li S; Wang Z; Ren Y
    Int J Cardiol; 2019 Oct; 293():159-164. PubMed ID: 31153654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New therapeutic era in heart failure with reduced ejection fraction: Which population of French patients is concerned?].
    Juillière Y; Ferrières J
    Ann Cardiol Angeiol (Paris); 2016 Sep; 65(4):237-9. PubMed ID: 27242321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher medication doses in heart failure?
    McCormack J; McAlister FA; Kolber MR
    Can Fam Physician; 2017 Jan; 63(1):e20. PubMed ID: 28115456
    [No Abstract]   [Full Text] [Related]  

  • 17. Lisinopril for hypertension.
    Med Lett Drugs Ther; 1988 Apr; 30(763):41-2. PubMed ID: 2832713
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beta blockers and ACE inhibitors In heart failure to be combined at the beginning!].
    MMW Fortschr Med; 2002 Nov; 144(45):58. PubMed ID: 12534067
    [No Abstract]   [Full Text] [Related]  

  • 19. Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure.
    Tavazzi L; Maggioni AP; Borer JS
    Eur Heart J; 2013 Sep; 34(36):2792-4. PubMed ID: 23892200
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin receptor--neprilysin inhibiton (ARNI)--a novel therapeutic concept for management of hypertension and heart failure.
    Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S
    Blood Press; 2012 Dec; 21(6):329-30. PubMed ID: 23210746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.